title: [Treatment of tobacco dependence: brief and intensive clinical intervention].
abstract: This article presents a literature review on the different methods of tobacco cessation that proved their efficiency through the recent meta-analyses. Smoking help cessation can consist in a systematic minimal advice that must be achieved physician or other professional of health throughout during their contact with their patients. This minimal intervention permits to get 5% of tobacco abstinence. The intensive clinical intervention is a very useful to higher dependent smokers or presenting anxiety and depressive disorders. It consists in a psychological combined approach by a behavioral and cognitive therapy and a pharmacological approach with two types of treatment: nicotine replacement therapy and the bupropion, the other "methods" not having proven their efficiency. The success rate of this intervention depends in the time of contact and the number of session. In order to promote tobacco cessation, it is necessary to widen the pharmacological product range and to educate health professionals in smoking cessation.
authors.affiliation: Institut National de santé publique, Hôpital Charle Nicolle, Tunis.
authors.forename: Radhouane
authors.initials: R
authors.lastname: Fakhfakh
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hsairi
authors.forename: Leila
authors.initials: L
authors.lastname: Gharbi
authors.forename: Hichem
authors.initials: H
authors.lastname: Aouina
authors.forename: Hend
authors.initials: H
authors.lastname: Bouacha
authors.forename: Noureddine
authors.initials: N
authors.lastname: Achour
mesh_terms: D001007:Anxiety; D016642:Bupropion / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003863:Depression / Q000209:etiology / Q000517:prevention & control; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D005731:Ganglionic Stimulants; D006282:Health Personnel; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000628:therapy*
chemical_list: D018765:Dopamine Uptake Inhibitors; D005731:Ganglionic Stimulants; D016642:Bupropion; D009538:Nicotine